Punjab Chemicals & Crop Protection
Revenue grew 28% YoY, but margins faced pressure from new product pricing and raw material inflation. PAT declined 9.3% in H1 due to lower 'other income' compared to last year.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Punjab Chemicals & Crop Protection earnings call we streamed: the live audio and our summary of what management said.
Revenue grew 28% YoY, but margins faced pressure from new product pricing and raw material inflation. PAT declined 9.3% in H1 due to lower 'other income' compared to last year.
Revenue grew 28% YoY, but margins faced pressure from new product pricing and raw material inflation. PAT declined 9.3% in H1 due to lower 'other income' compared to last year.
Management expects Q3 and Q4 to recover deferred export demand and maintain previous annual guidance.
Management maintains a 15-20% revenue growth target despite a weak demand environment and pricing pressure in India and Europe, relying on a robust order book for H2 recovery.
Punjab Chemicals delivered record FY26 revenue of ₹1,030cr (+14.4%) and PAT of ₹64cr (+64.3%), driven by stable volumes and a shift toward higher-margin growth phases in agrochemicals.
Punjab Chemicals delivered record annual revenue with 14% growth, transitioning from consolidation to a growth phase driven by new molecules.
PCCPL delivered robust FY26 results with revenue crossing ₹1,000 Cr, driven by strong growth in PAT and EBITDA margins through product mix optimization and operational efficiencies.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.